The precise localization and role of InsP 3 R in cardiac muscle cells are largely unknown.
Introduction
Inositol 1,4,5-trisphosphate receptors (InsP 3 Rs) and ryanodine receptors (RyRs) are intracellular calcium release channels. In cardiac muscle it has been well established that the role of RyRs is to release calcium during excitation-contraction coupling. In contrast, the role of InsP 3 Rs in cardiac myocytes is not clear. It has been proposed that InsP 3 Rs are involved in intercellular signaling because they have been found in Purkinje myocytes of the conduction system at high levels 17 and in intercalated discs 25 . InsP 3 Rs are also involved in intracellular signaling since InsP 3 has been shown to elicit slow calcium release and activate contractions in skinned ventricular muscle or permeabilized cells 21, 24, 53 and have been isolated from the sarcoplasmic reticulum of interventricular septum tissue 5 . Interestingly, other studies have also suggested that InsP 3 Rs may play a signaling role related to cell growth since these receptors are the first release channels expressed in embryos and both InsP 3 -dependent and -independent pathways persist during development 35, 44 .
The idea of InsP 3 R involvement in cell growth is supported by experiments performed by other investigators in which long-term activation of signaling pathways that generate InsP 3 results in expression of genes involved in cellular hypertrophy 3, 10, 14, 55 . However, how cardiac cells discriminate between the InsP 3 -induced changes in calcium and the large and cyclic fluctuations of calcium during excitation-contraction coupling is unknown. Furthermore, it is also unknown how InsP 3 Rs may alter expression of genes during cell growth. The phenomenon of slow waves of calcium or calcium oscillations promoting expression of hypertrophic genes in other systems 8, 23 does not fit with the normal functioning of cardiac cells since they experience rhythmic elevations of calcium at a much faster rate. Thus, cardiac myocytes must tightly regulate the factors that alter gene expression. A plausible explanation is that calcium release by 3 InsP 3 R in cardiac myocytes occurs at discrete sites where it would have a direct effect on gene expression. To test this hypothesis, we investigated the localization of InsP 3 Rs, their ability to release calcium, and a possible regulatory function of these receptors on the expression of some of the hypertrophic marker genes.
The results reveal previously unidentified presence of type 2 InsP 3 Rs (InsP 3 Rs-2) associated with the nuclear region and in striations in cardiac myocytes. In addition, the data provide strong evidence in favor of InsP 3 R-2 involvement in intracellular signaling and promotion of cardiac cell growth. 4 
Materials and Methods

Cell isolation
The experiments were approved by the Animal Care and Use Committee of the University of Illinois at Chicago and followed the guidelines of the National Institutes of Health.
Primary cultures were prepared from cardiac muscle of postnatal day 0 mice (stock CACNA1SxNIHS-BCfBR) as described previously Probes) and used at a 1:750 dilution. Cells were incubated for 2 hours in the primary antibody and 2 hours in the secondary. After incubation with the secondary antibody, cells were rinsed twice with PBS containing 0.2% RNAse. To label the nuclei, cells were exposed to 3 µM TO-PRO3 (Molecular Probes), which binds to double stranded nucleic acid. In some cases, actin filaments were also labelled with rhodamine phalloidin (1:1000 dilution; Molecular Probes).
Images of 512 X 512 pixels were collected in xy with a pinhole size of 1. Calcium events were recorded in line scan mode as we previously described 46 Emission was measured at wavelengths of 515 ± 30 nm. Rhodamine phalloidin was excited with the 568 nm line of the laser and its emission was measured at 600 ± 40 nm. TO-PRO3 was excited at 637 nm and the emission was measured at wavelengths >660 nm.
Measurement of gene expression
Total RNA was isolated from control or treated cells from the same culture and following manufacturer's instructions (QIAGEN). RNA (0.2 µg) was mixed with 100 pmol random hexamer primers (Roche) and heated to 70°C for 2 min. After denaturation, the mix was added to the reverse transcription cocktail containing 200 U of M-MuLV reverse transcriptase and incubated for 1 hour at 37°C. Gene-specific PCR was performed using 3 µl of the amplified cDNA (10 µl when measuring α2δ1-c) in a 50 µl volume with 1X PCR buffer, 1.5 mM MgCl 2 , 1 mM dNTP, 0.5 U Taq DNA polymerase (Eppendorf) and 10 pmole of each primer. The gene of interest and GAPDH were simultaneously amplified in a single PCR reaction tube to allow direct 7 comparison of the relative amounts of message. PCR amplification was performed within the linear range as we previously determined for these genes 2 .
Western blotting
Cellular fractions were separated from isolated neonatal cells using a subcellular proteome extraction kit (Calbiochem) following manufacturer's instructions for cells in suspension. The four fractions obtained (cytosol, membrane/organelle, nucleus, and cytoskeleton) were used immediately or stored at -80 o C until use. Proteins were separated by SDS-polyacrylamide gel electrophoresis using 7.5% gels and transferred to PVDF membranes.
The membranes were incubated with the amino-terminal anti-InsP 3 R-2 primary antibody used for immunolocalization of InsP 3 Rs with confocal microscopy at a 1:1000 dilution. After washing and blocking, membranes were incubated with a secondary antibody conjugated to horseradish peroxidase at a 1:20,000 dilution. Antibody binding was detected with chemiluminescence using the SuperSignal West Femto Detection Kit (Pierce) following manufacturer's instructions. To determine the purity of these fractions, blots were also examined with antibodies against specific proteins in each subcellular fraction: anti-calpain-1 (Affinity Bioreagents, Inc.) for the cytosolic fraction; anti-SERCA2a (Sigma) for the membrane/organelle fraction; anti-histone deacetylase-2 (Zymed Laboratories, Inc.) for the nuclear fraction; and anti-desmin (Sigma) for the cytoskeleton fraction. These antibodies were also detected with chemiluminescence. The distributions of the signals in the cytosol, membrane/organelle, nucleus, and cytoskeleton fractions, respectively, for three determinations were as follows (mean ± sem): calpain-1, 94±2%, 4±0.3%, 2±0.6%, 0%; SERCA2a, 2±0.6%, 95±0.4%, 3±0.9%, 0%; histone deacetylase-2, 0%, 1.7±0.3, 98±0.9, 0.7±0.7%; and desmin, 3±1.2%, 3.7±0.3%, 3.3±0.3%, 90±0.9%. 
Results
Immunolocalization of InsP 3 Rs
Localization of InsP 3 Rs was studied in primary cultures of murine neonatal cardiac myocytes with confocal microscopy. InsP 3 Rs types 1-3 have been found in mouse, rat, and ferret hearts 12, 29, 40, 51, 54 . Although the proportions of each isoform vary from report to report, the consensus is that type 2 is the most prominent isoform in preparations of ventricular tissue and the only isoform detected in isolated neonatal cardiocytes 40 . Thus, the pattern of InsP 3 Rs expression in our cardiac cell culture was investigated with antibodies against InsP 3 Rs types 1-3.
Sarcomeric actin and the nucleus were labelled using rhodamine phalloidin and TO-PRO3, respectively. In agreement with a previous report using adult mouse hearts 12 , the predominant species of InsP 3 Rs found in our preparations were types 1 and 2. However, the distribution of these two isoforms was quite distinct. InsP 3 Rs-1 were not detected in myocytes ( To further demonstrate that InsP3Rs-2 mediated the release events, calcium release was recorded from saponin-permeabilized myocytes without actin staining and before and after the addition of InsP 3 R antagonists. Recordings were initially performed in the presence of Adenophostin-A, 100 nM calcium, and 100 µM tetracaine. Fig. 5c shows two calcium events that occurred simultaneously in the same cell. One of the events localized towards the center of the nuclear region and the other close to the periphery of the nucleus. The events recorded using 12 line scan under these conditions had an average amplitude of 0.9 ± 0.08 F/Fo, duration of 112.4 ± 7.4 ms, and an average width of 3.2 ± 1.1 µm measured at 50% of the maximum amplitude (n=152 events). These values fall within the range of those measured in a wide variety of cells 4, 38, 49 , including cardiac myocytes 56 . As shown in Fig. 5d , the calcium release events completely disappeared immediately after the cells were exposed to the InsP 3 R blockers APB (40 µM) or XeC (100 µM), clearly confirming mediation by InsP 3 Rs.
Potential modulation of gene expression by InsP 3 Rs-2
To determine the role of calcium release in the nuclear domains, we measured gene Cardiac cells were exposed to the agonists endothelin-1 (1 µM) or phenylephrine (10 µM) for 48-72 hours to stimulate the hypertrophic response. Endothelin-1 and phenylephrine significantly increased the expression of both ANF and skeletal α-actin genes (Fig. 6) . The average increase of ANF and skeletal α-actin message with endothelin-1 was 2.05 ± 0.3 (n= 9 cultures) and 1.87 ± 0.32 (n= 6 cultures) times over control conditions, respectively (p<0.05). The corresponding average increase with phenylephrine was 1.90 ± 0.35 (n= 7 cultures) and 1.65 ± 0.28 (n= 6 cultures) times over control, respectively (p<0.05). Although the expression of ANF and skeletal α-actin was significantly higher in the presence of the hypertrophic agonists than in control conditions, the increase is smaller than that found in previous studies using rat cardiac 13 myocytes 3,13,14,26 , which most likely is a reflection of the difference in species 11, 45 . Furthermore, it should be noted that hypertrophy of mouse myocytes in response to receptor activation in vitro has been seen by some investigators 27,34,37,42,52 but not by others 11, 45 , probably reflecting differences in culture conditions. In our experiments, exposure of the myocytes to APB (40 µM) or XeC (20 µM) resulted in a marked inhibition of expression of these two genes. It has been reported that APB and XeC can affect the calcium transporters SERCA2 and RyR in addition to InsP 3 R and result in depletion of the endoplasmic reticulum in other cell types 6, 18, 22, 39, 41, 47 . To determine whether the InsP 3 R antagonists had deleterious secondary effects in neonatal myocytes at the concentrations used here, we treated myocytes with thapsigargin (1-2 µM) to block SERCA2 and deplete the sarcoplasmic reticulum of calcium. However, these conditions were detrimental for the cells since they detached from the culture dishes and did not last for the duration of the experiment. We also exposed myocytes to tetracaine and found that it did not prevent the change in gene expression promoted by endothelin-1 or phenylephrine. Thus, our results suggest that InsP 3 Rs mediate the increase in mRNA levels.
Unexpectedly, the reduction in mRNA levels by the InsP 3 R blockers was of a magnitude sufficient to suggest that InsP 3 R activation is critical to the basal expression of ANF and skeletal α-actin. To test this hypothesis, myocytes were treated with the blockers in the absence of the two hypertrophic markers examined here since GAPDH levels were not affected by the two hypertrophic agents (Fig. 6) . As an additional control, we verified that L-type calcium channel subunit α2δ1-C expression was not modified by treatment with either endothelin-1 or the InsP 3 R blockers (Fig. 7d) . The average levels of α2δ1-C subunit were 0.95 ± 0.11 and 1.07 ± 0.12 of control in the presence of endothelin-1 or endothelin-1 plus APB, respectively. Thus, these experiments corroborate the specificity of InsP 3 Rs in modulating expression of some hypertrophic genes. While InsP 3 Rs-2 have also been found associated with the nucleus of other cell types 28 , our work is the first to show that this calcium release channel is localized in association with the nucleus and the sarcomeres of cardiac myocytes. Quite possibly, these receptors are embedded in the tubular membrane-bound invaginations of the nuclear envelope proposed to exist initially by 18 Lui et al 31 
